Coming Soon: Oxaydo for Pain Management
Tablets will be available in 5mg and 7.5mg strength.
Oxaydo is formerly known as Oxecta (Pfizer).
Oxaydo, a CII controlled substance, is the first immediate-release oxycodone formulation to deter abuse via snorting.
Oxycodone HCl is is a pure opioid agonist and is relatively selective for the mu receptor, although it can interact with other opioid receptors at higher doses. Its principal therapeutic action is analgesia.
Oxaydo will be available in 5mg and 7.5mg strength tablets in 100-count bottles. It is anticipated to launch in the third quarter of 2015.
For more information call (855) 228-7201 or visit Egalet.com.